Change of hypothalamic adult neurogenesis in mice by chronic treatment of fluoxetine

BMC Research Notes

Koji Ohira¹ 

[1] Laboratory of Nutritional Brain Science, Department of Food Science and Nutrition, Mukogawa Women’s University, 6-46 Ikebiraki, 663-8558, Nishinomiya, Hyogo, Japan;

关键词: Adult neurogenesis;    Antidepressant;    Hypothalamus;    Neural stem cell;   

DOI  :  10.1186/s13104-022-05954-z

来源: Springer

【 摘 要 】

ObjectiveMore than half of patients with depression display eating disorders, such as bulimia nervosa and anorexia nervosa. Feeding centers are located in the hypothalamus, and hypothalamic adult neurogenesis has an important role in feeding and energy balance. Antidepressants, which can regulate adult neurogenesis in the hippocampus, olfactory bulb, and neocortex, are used for eating disorders, but it is unclear whether antidepressants change hypothalamic adult neurogenesis. In this study, we used immunohistological analysis to assess effects of the antidepressant fluoxetine (FLX) on hypothalamic adult neurogenesis of adult mice.ResultsExpressions of the proliferating cell marker, Ki67, and the neural stem cell marker, nestin, were significantly decreased in the hypothalamus by FLX. As regard to postmitotic cells, the number of the neural marker, NeuN, positive cells was significantly upregulated by FLX, but that of the astrocytic marker, S100B, positive cells was significantly reduced by FLX. The number of the oligodendrocyte marker, Olig2, positive cells was not changed by FLX. Interestingly, FLX treatment did not affect the total number of newly generated cells in the hypothalamus, comparing that in controls. These results suggest that FLX treatment influence hypothalamic adult neurogenesis and shift the balance between the numbers of neurons and astrocytes under studied conditions.

【 授权许可】

CC BY